HbA1c testing frequency: a review of the clinical evidence and guidelines
CADTH
Record ID 32015000149
English
Authors' recommendations:
Although there was the suggestion of potential benefit to shortened HbA1c testing intervals for some patients in non-randomized studies, evidence from a randomized controlled trial indicated that clinical outcomes for well-controlled patients tested at 3- or 6-month intervals were equivalent. Studies demonstrated that adherence to guidelines was able to improve variations in HbA1c levels. Clinical practice guidelines generally agree that HbA1c testing every six months is appropriate for patients who are well controlled. For those patients that have poorly controlled diabetes or who are making changes in their therapeutic regimen a testing once every three months was advised.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/htis/dec-2014/RC0593%20HbA1c%20Testing%20Frequency%20final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Guideline Adherence
- Diabetes Mellitus
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.